Ryan J McDonough1, Mark A Clements1,2,3, Stephen A DeLurgio4, Susana R Patton5,6,7. 1. Department of Pediatrics, Division of Endocrinology/Diabetes, Children's Mercy - Kansas City, Kansas City, MO, USA. 2. Department of Pediatrics, University of Kansas Medical Center, Kansas City, KS, USA. 3. Department of Pediatrics, University of Missouri Kansas City, Kansas City, MO, USA. 4. Center for Health Outcomes and Health Services Research, Children's Mercy - Kanasas City, Kansas City, MO, USA. 5. Center for Children's Healthy Lifestyles and Nutrition, Children's Mercy - Kansas City, Kansas City, MO, Kansas City, MO, USA. 6. University of Kansas Medical Center, Kansas City, KS, USA. 7. Department of Pediatrics, Division of Behavioral Pediatrics, University of Kansas Medical Center, Kansas City, KS, USA.
Abstract
BACKGROUND: Adherence to the type 1 diabetes (T1D) regimen, while predictive of glycemic control, decreases during adolescence. For adolescents, attaining adequate sleep is an additional challenge. This study evaluates the impact of sleep on adherence in teens with T1D. SUBJECTS: Forty-five adolescents aged 12-18 yr, with T1D for at least 6 months while on insulin pump therapy. METHODS: Adolescents logged their sleep on a written diary for 2 wk. Corresponding insulin pump/glucometer downloads as well as sleep habit questionnaires were also obtained. RESULTS: Data from 20 girls and 25 boys, with a mean age of 15 ± 1.6 yr and mean glycated hemoglobin of 8.7 ± 1.1% (72 mmol/mol), were analyzed. Overall, average sleep was 8.6 ± 0.9 h per night. Sleep durations were compared to the next day's frequency of self-monitored blood glucose (SMBG) and total daily insulin bolus frequency. Associations were found between sleep duration and youths' SMBG and insulin bolus frequencies (p < 0.03 and p < 0.001, respectively). Specifically, a 15- and 20-min increase in sleep was associated with one additional SMBG check and one additional insulin bolus, respectively. CONCLUSION: Analyses suggest an associated increase in T1D self-management behaviors in youths with increased sleep duration. These findings highlight the importance of assessing sleep in clinical practice, and encourage further research to examine effective strategies to address sleep hygiene as part of routine diabetes management.
BACKGROUND: Adherence to the type 1 diabetes (T1D) regimen, while predictive of glycemic control, decreases during adolescence. For adolescents, attaining adequate sleep is an additional challenge. This study evaluates the impact of sleep on adherence in teens with T1D. SUBJECTS: Forty-five adolescents aged 12-18 yr, with T1D for at least 6 months while on insulin pump therapy. METHODS: Adolescents logged their sleep on a written diary for 2 wk. Corresponding insulin pump/glucometer downloads as well as sleep habit questionnaires were also obtained. RESULTS: Data from 20 girls and 25 boys, with a mean age of 15 ± 1.6 yr and mean glycated hemoglobin of 8.7 ± 1.1% (72 mmol/mol), were analyzed. Overall, average sleep was 8.6 ± 0.9 h per night. Sleep durations were compared to the next day's frequency of self-monitored blood glucose (SMBG) and total daily insulin bolus frequency. Associations were found between sleep duration and youths' SMBG and insulin bolus frequencies (p < 0.03 and p < 0.001, respectively). Specifically, a 15- and 20-min increase in sleep was associated with one additional SMBG check and one additional insulin bolus, respectively. CONCLUSION: Analyses suggest an associated increase in T1D self-management behaviors in youths with increased sleep duration. These findings highlight the importance of assessing sleep in clinical practice, and encourage further research to examine effective strategies to address sleep hygiene as part of routine diabetes management.
Authors: Sarah S Jaser; Emily R Hamburger; Erin M Bergner; Rodayne Williams; James C Slaughter; Jill H Simmons; Beth A Malow Journal: Pediatr Diabetes Date: 2020-02-11 Impact factor: 4.866
Authors: Niral J Patel; Kimberly L Savin; Sachini N Kahanda; Beth A Malow; Lauren A Williams; Gray Lochbihler; Sarah S Jaser Journal: Pediatr Diabetes Date: 2018-04-30 Impact factor: 4.866
Authors: Karen A Landmeier; Monica Lanning; David Carmody; Siri Atma W Greeley; Michael E Msall Journal: Pediatr Diabetes Date: 2016-08-24 Impact factor: 4.866
Authors: Sarah S Jaser; Erin M Bergner; Emily R Hamburger; Shivani Bhatia; Morgan Lyttle; Grace E Bell; J Christopher Slaughter; Beth A Malow; Jill H Simmons Journal: J Pediatr Psychol Date: 2021-03-18